azathioprine has been researched along with Arteriosclerosis, Coronary in 6 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sirolimus was not found to be superior to mycophenolate mofetil in a randomized trial." | 2.44 | Proliferation signal inhibitors in cardiac transplantation. ( Gustafsson, F; Ross, HJ, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keogh, A | 2 |
| Richardson, M | 1 |
| Ruygrok, P | 1 |
| Spratt, P | 1 |
| Galbraith, A | 1 |
| O'Driscoll, G | 1 |
| Macdonald, P | 1 |
| Esmore, D | 1 |
| Muller, D | 1 |
| Faddy, S | 1 |
| Gustafsson, F | 1 |
| Ross, HJ | 1 |
| Aziz, TM | 1 |
| Sheldon, S | 1 |
| el-Gamel, A | 1 |
| Krysiak, P | 1 |
| Campbell, C | 1 |
| Rahman, A | 1 |
| Dyer, P | 1 |
| Yonan, N | 1 |
| Deiraniya, A | 1 |
| Sartori, TM | 1 |
| Maurizio, PG | 1 |
| Sara, P | 1 |
| Ugolino, L | 1 |
| Annalisa, A | 1 |
| Panagiotis, T | 1 |
| Massimo, F | 1 |
| Antonio, G | 1 |
| Carrier, M | 1 |
| White, M | 1 |
| Perrault, LP | 1 |
| Pelletier, GB | 1 |
| Pellerin, M | 1 |
| Robitaille, D | 1 |
| Pelletier, LC | 1 |
| Rose, ML | 1 |
| Smith, J | 1 |
| Dureau, G | 1 |
| Kobashigowa, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Early Vs Late Sirolimus-Initiation Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients[NCT01305395] | 0 participants (Actual) | Interventional | 2010-11-30 | Withdrawn (stopped due to Due in part, to reduced transplant volume and enrollment has been difficult.) | |||
| Assessment of Cardiac Allograft Vasculopathy (CAV) by Optical Coherence Tomography (OCT)[NCT02503566] | 150 participants (Anticipated) | Interventional | 2014-09-01 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for azathioprine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Proliferation signal inhibitors in cardiac transplantation.
Topics: Azathioprine; Calcineurin; Calcineurin Inhibitors; Cell Proliferation; Coronary Artery Disease; Dose | 2007 |
3 trials available for azathioprine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial.
Topics: Acute Disease; Adult; Azathioprine; Coronary Artery Disease; Creatinine; Follow-Up Studies; Graft Re | 2004 |
Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial.
Topics: Acute Disease; Adult; Azathioprine; Coronary Artery Disease; Creatinine; Follow-Up Studies; Graft Re | 2004 |
Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial.
Topics: Acute Disease; Adult; Azathioprine; Coronary Artery Disease; Creatinine; Follow-Up Studies; Graft Re | 2004 |
Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial.
Topics: Acute Disease; Adult; Azathioprine; Coronary Artery Disease; Creatinine; Follow-Up Studies; Graft Re | 2004 |
A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation.
Topics: Adult; Analysis of Variance; Antilymphocyte Serum; Azathioprine; Coronary Artery Disease; Cyclospori | 1999 |
Mycophenolate mofetil decreases antibody production after cardiac transplantation.
Topics: Antibody Formation; Azathioprine; Coronary Angiography; Coronary Artery Disease; Disease Progression | 2002 |
2 other studies available for azathioprine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Implication of HLA mismatch in the clinical outcome of orthotopic heart transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Child; Coronary Artery Disease; Cyclosporine; | 1998 |
Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation.
Topics: Azathioprine; Biopsy; Coronary Artery Disease; Cyclosporine; Drug Therapy, Combination; Female; Fibr | 1999 |